Bausch Health Cos Total Long Term Liabilities 2010-2024 | BHC

Bausch Health Cos total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Bausch Health Cos Annual Total Long Term Liabilities
(Millions of US $)
2023 $23,130
2022 $21,485
2021 $24,038
2020 $25,681
2019 $26,479
2018 $25,841
2017 $27,285
2016 $36,662
2015 $37,623
2014 $18,195
2013 $20,225
2012 $12,410
2011 $8,254
2010 $5,192
2009 $456
Bausch Health Cos Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $22,353
2024-03-31 $22,682
2023-12-31 $23,130
2023-09-30 $23,075
2023-06-30 $21,265
2023-03-31 $21,377
2022-12-31 $21,485
2022-09-30 $22,034
2022-06-30 $22,921
2022-03-31 $24,457
2021-12-31 $24,038
2021-09-30 $23,950
2021-06-30 $25,136
2021-03-31 $25,423
2020-12-31 $25,681
2020-09-30 $26,175
2020-06-30 $26,132
2020-03-31 $26,189
2019-12-31 $26,479
2019-09-30 $25,372
2019-06-30 $25,961
2019-03-31 $25,831
2018-12-31 $25,841
2018-09-30 $26,378
2018-06-30 $26,816
2018-03-31 $27,285
2017-12-31 $27,285
2017-09-30 $29,824
2017-06-30 $33,239
2017-03-31 $34,092
2016-12-31 $36,662
2016-09-30 $37,591
2016-06-30 $38,033
2016-03-31 $38,647
2015-12-31 $37,623
2015-09-30 $37,339
2015-06-30 $37,494
2015-03-31 $28,894
2014-12-31 $18,195
2014-09-30 $18,683
2014-06-30 $20,032
2014-03-31 $20,223
2013-12-31 $20,225
2013-09-30 $20,290
2013-06-30 $12,318
2013-03-31 $12,253
2012-12-31 $12,410
2012-09-30 $9,203
2012-06-30 $9,275
2012-03-31 $8,585
2011-12-31 $8,254
2011-09-30 $6,942
2011-06-30 $6,401
2011-03-31 $6,318
2010-12-31 $5,192
2010-09-30 $4,940
2010-06-30 $435
2010-03-31 $453
2009-12-31 $456
2009-09-30 $512
2009-06-30 $587
2009-03-31 $150
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00